These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7995987)

  • 1. Protective effects of an N-terminal fragment of bactericidal/permeability-increasing protein in rodent models of gram-negative sepsis: role of bactericidal properties.
    Ammons WS; Kohn FR; Kung AH
    J Infect Dis; 1994 Dec; 170(6):1473-82. PubMed ID: 7995987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.
    Lin Y; Leach WJ; Ammons WS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):65-9. PubMed ID: 8787881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis.
    Evans TJ; Carpenter A; Moyes D; Martin R; Cohen J
    J Infect Dis; 1995 Jan; 171(1):153-60. PubMed ID: 7798655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein.
    Kohn FR; Kung AH
    Infect Immun; 1995 Jan; 63(1):333-9. PubMed ID: 7806373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a recombinant amino terminal fragment of bactericidal/permeability increasing protein in rodents challenged with LPS or E. coli bacteria.
    Kung AH; Ammons WS; Lin Y; Kohn FR
    Prog Clin Biol Res; 1994; 388():255-63. PubMed ID: 7831363
    [No Abstract]   [Full Text] [Related]  

  • 6. Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties.
    Schlag G; Redl H; Davies J; Scannon P
    Ann Surg; 1999 Feb; 229(2):262-71. PubMed ID: 10024109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
    Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
    Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria.
    Domingues MM; Silva PM; Franquelim HG; Carvalho FA; Castanho MA; Santos NC
    Nanomedicine; 2014 Apr; 10(3):543-51. PubMed ID: 24262996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal/permeability-increasing protein attenuates systemic inflammation and acute lung injury in porcine lower limb ischemia-reperfusion injury.
    Harkin DW; Barros D'Sa AA; McCallion K; Hoper M; Halliday MI; Campbell FC
    Ann Surg; 2001 Aug; 234(2):233-44. PubMed ID: 11505070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria.
    Wiese A; Brandenburg K; Carroll SF; Rietschel ET; Seydel U
    Biochemistry; 1997 Aug; 36(33):10311-9. PubMed ID: 9254630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant bactericidal/permeability-increasing protein on endotoxin translocation and lipopolysaccharide-binding protein/CD14 expression in rats after thermal injury.
    Fang WH; Yao YM; Shi ZG; Yu Y; Wu Y; Lu LR; Sheng ZY
    Crit Care Med; 2001 Jul; 29(7):1452-9. PubMed ID: 11445707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease.
    Srivastava A; Casey H; Johnson N; Levy O; Malley R
    Infect Immun; 2007 Jan; 75(1):342-9. PubMed ID: 17101667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability increasing protein (rBPI21) after liver surgery in rats and humans.
    Wiezer MJ; Langendoen SI; Meijer C; Bauer RJ; White ML; Carroll SF; Meyer S; Thijs LG; van Leeuwen PA
    Shock; 1998 Sep; 10(3):161-6; discussion 167-8. PubMed ID: 9744643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia.
    Kohn FR; Ammons WS; Horwitz A; Grinna L; Theofan G; Weickmann J; Kung AH
    J Infect Dis; 1993 Nov; 168(5):1307-10. PubMed ID: 8228369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
    Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
    J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.